test

BRIANNE SHERGILL

@Exome Asset Management Llc

Latest period2024 - Q3ReportedManaged Assets$293.574MTotal holdings59
Assets growth rate161.38%Assets growth rate (2-Q avg)78.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Exome Asset Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 59 positions.

Assets under management

The assets under management (AUM) of Exome Asset Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 293.574M in assets, with a quarterly growth rate of 161.38% and a 2-quarter average growth rate of 78.78%. The portfolio is managed by BRIANNE SHERGILL, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BMYBristol-myers Squibb Co
Recent Activity
New Position
2.75%
$8.071M
156,000 shares@ $51.74 avg price
VRDNViridian Therapeutics Inc
Recent Activity
New Position
2.71%
$7.935M
348,800 shares@ $22.75 avg price
ISRGIntuitive Surgical Inc
Recent Activity
Increased 133.63%
2.49%
$7.297M
14,854 shares@ $491.27 avg price
BGNEBeigene Ltd
Recent Activity
Decreased -7.83%
2.35%
$6.87M
30,600 shares@ $224.51 avg price
BPMCBlueprint Medicines Corp
Recent Activity
New Position
2.32%
$6.79M
73,400 shares@ $92.5 avg price
GKOSGlaukos Corp
Recent Activity
New Position
2.3%
$6.737M
51,714 shares@ $130.29 avg price
SWTXSpringworks Therapeutics Inc
Recent Activity
New Position
2.2%
$6.453M
201,400 shares@ $32.04 avg price
IRONDisc Medicine Inc
Recent Activity
Increased 111.53%
2.16%
$6.341M
129,032 shares@ $49.14 avg price
CYTKCytokinetics Inc
Recent Activity
New Position
2.11%
$6.186M
117,166 shares@ $52.8 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
New Position
2.01%
$5.883M
132,400 shares@ $44.43 avg price